1.1. Executive Summary: Global Breast Biopsy Devices Market

2.1. Research Objective

2.2. Product Overview

2.3. Market Segmentation

2.4. Qualitative Research
2.4.1. Primary & Secondary Sources

2.5. Quantitative Research
2.5.1. Primary & Secondary Sources

2.6. Breakdown of Primary Research Respondents, By Region

2.7. Assumption for Study

2.8. Market Size Estimation

2.9. Data Triangulation

3.1. Industry Value Chain Analysis
3.1.1. Raw Material & Component Suppliers (Needles, Probes, Imaging Components)
3.1.2. Breast Biopsy Device Manufacturers
3.1.3. Imaging & Guidance Technology Providers
3.1.4. Distributors & Medical Device Dealers
3.1.5. Healthcare Providers (Hospitals, Imaging Centers, ASCs, Specialty Clinics)
3.1.6. End Patients

3.2. Industry Outlook
3.2.1. Overview of the Global Breast Cancer Diagnostics & Imaging Industry
3.2.2. Shift Toward Minimally Invasive & Image-Guided Biopsy
3.2.3. Regulatory & Reimbursement Landscape (FDA, CE/EU MDR, Coverage Policies)

3.3. PESTLE Analysis

3.4. Porter's Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitutes
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition

3.5. Market Growth and Outlook
3.5.1. Market Revenue Estimates and Forecast (US$ Mn), 2020-2035
3.5.2. Price Trend Analysis, By Product Type

4.1. Competition Dashboard
4.1.1. Market Concentration Rate
4.1.2. Company Market Share Analysis (Value %), 2025
4.1.3. Competitor Mapping & Benchmarking

5.1. Market Dynamics and Trends
5.1.1. Growth Drivers
5.1.2. Restraints
5.1.3. Opportunity
5.1.4. Key Trends

5.2. Market Size and Forecast, 2020-2035 (US$ Mn)
5.2.1. By Product Type
5.2.1.1. Key Insights
5.2.1.1.1. Core Needle Biopsy Devices
5.2.1.1.2. Vacuum-Assisted Biopsy Devices
5.2.1.1.3. Fine Needle Aspiration (FNA) Devices
5.2.1.1.4. Localization Devices
5.2.1.1.5. Biopsy Guidance Systems
5.2.2. By Procedure Type
5.2.2.1. Key Insights
5.2.2.1.1. Minimally Invasive Breast Biopsy
5.2.2.1.2. Surgical Breast Biopsy
5.2.3. By Guidance Technology
5.2.3.1. Key Insights
5.2.3.1.1. Ultrasound-Guided Biopsy
5.2.3.1.2. Stereotactic-Guided Biopsy
5.2.3.1.3. MRI-Guided Biopsy
5.2.3.1.4. Tomosynthesis-Guided Biopsy
5.2.4. By End User
5.2.4.1. Key Insights
5.2.4.1.1. Hospitals
5.2.4.1.2. Diagnostic Imaging Centers
5.2.4.1.3. Ambulatory Surgical Centers
5.2.4.1.4. Specialty Clinics
5.2.5. By Region
5.2.5.1. Key Insights
5.2.5.1.1. North America
5.2.5.1.1.1. The U.S.
5.2.5.1.1.2. Canada
5.2.5.1.1.3. Mexico
5.2.5.1.2. Europe
5.2.5.1.2.1. Western Europe
5.2.5.1.2.1.1. The UK
5.2.5.1.2.1.2. Germany
5.2.5.1.2.1.3. France
5.2.5.1.2.1.4. Italy
5.2.5.1.2.1.5. Spain
5.2.5.1.2.1.6. Rest of Western Europe
5.2.5.1.2.2. Eastern Europe
5.2.5.1.2.2.1. Poland
5.2.5.1.2.2.2. Russia
5.2.5.1.2.2.3. Rest of Eastern Europe
5.2.5.1.3. Asia Pacific
5.2.5.1.3.1. China
5.2.5.1.3.2. India
5.2.5.1.3.3. Japan
5.2.5.1.3.4. Australia & New Zealand
5.2.5.1.3.5. South Korea
5.2.5.1.3.6. ASEAN
5.2.5.1.3.7. Rest of Asia Pacific
5.2.5.1.4. Middle East & Africa (MEA)
5.2.5.1.4.1. Saudi Arabia
5.2.5.1.4.2. South Africa
5.2.5.1.4.3. UAE
5.2.5.1.4.4. Rest of MEA
5.2.5.1.5. South America
5.2.5.1.5.1. Argentina
5.2.5.1.5.2. Brazil
5.2.5.1.5.3. Rest of South America

6.1. Market Dynamics and Trends
6.1.1. Growth Drivers
6.1.2. Restraints
6.1.3. Opportunity
6.1.4. Key Trends

6.2. Market Size and Forecast, 2020-2035 (US$ Mn)
6.2.1. Key Insights
6.2.1.1. By Product Type
6.2.1.2. By Procedure Type
6.2.1.3. By Guidance Technology
6.2.1.4. By End User
6.2.1.5. By Country

7.1. Market Dynamics and Trends
7.1.1. Growth Drivers
7.1.2. Restraints
7.1.3. Opportunity
7.1.4. Key Trends

7.2. Market Size and Forecast, 2020-2035 (US$ Mn)
7.2.1. Key Insights
7.2.1.1. By Product Type
7.2.1.2. By Procedure Type
7.2.1.3. By Guidance Technology
7.2.1.4. By End User
7.2.1.5. By Country

8.1. Market Dynamics and Trends
8.1.1. Growth Drivers
8.1.2. Restraints
8.1.3. Opportunity
8.1.4. Key Trends

8.2. Market Size and Forecast, 2020-2035 (US$ Mn)
8.2.1. Key Insights
8.2.1.1. By Product Type
8.2.1.2. By Procedure Type
8.2.1.3. By Guidance Technology
8.2.1.4. By End User
8.2.1.5. By Country

9.1. Market Dynamics and Trends
9.1.1. Growth Drivers
9.1.2. Restraints
9.1.3. Opportunity
9.1.4. Key Trends

9.2. Market Size and Forecast, 2020-2035 (US$ Mn)
9.2.1. Key Insights
9.2.1.1. By Product Type
9.2.1.2. By Procedure Type
9.2.1.3. By Guidance Technology
9.2.1.4. By End User
9.2.1.5. By Country

10.1. Market Dynamics and Trends
10.1.1. Growth Drivers
10.1.2. Restraints
10.1.3. Opportunity
10.1.4. Key Trends

10.2. Market Size and Forecast, 2020-2035 (US$ Mn)
10.2.1. Key Insights
10.2.1.1. By Product Type
10.2.1.2. By Procedure Type
10.2.1.3. By Guidance Technology
10.2.1.4. By End User
10.2.1.5. By Country

11.1. Argon Medical Devices, Inc.
11.2. BD
11.3. Cook
11.4. Danaher Corporation
11.5. Devicor Medical Products, Inc.
11.6. Fujifilm Corporation
11.7. GE HealthCare
11.8. Hoffmann-La Roche Ltd.
11.9. Hologic, Inc.
11.10. Merit Medical Systems, Inc.
11.11. QIAGEN
11.12. Other Prominent Players

12.1. List of Secondary Sources
12.2. Key Country Markets- Macro Economic Outlook/Indicators